WK1_7 Stem Cells Flashcards

1
Q

totipotency

A

the potential of a single cell to develop into a total organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pluripotency

A

a cell’s capacity to give rise to all cell types in the body but not to the supporting structures, such as the placenta, amnion, and chorion, all of which are needed fro the development of an organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

unipotency

A

a cell’s capacity to give rise to only one cell type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

multipotency

A

a cell’s capacity to give rise to a small number of different cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

iPS (induced pluripotent stem) cells

A

are engineered cells derived from somatic cells that resemble embryonic stem (ES) cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

criteria to establish a stem cell line:

A
  • forms an embryoid body
  • forms a teratoma-type tumor when implanted into immunodeficient mice
  • forms a chimera when implanted into early embryo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the advantages of patient specific iPS cell lines? (3)

A
  • differentiated cells will be a perfect immunological match to the donor, permitting grafting back without the use of immunosuppressive drugs
  • permits treatment of genetic diseases or cancers
  • tumor formation represent major concern due to mechanisms of viral gene insertion. host genes may be interrupted. in addition, silenced genes may be reactivated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the potential therapies using pluripotent stem cells (ES or iPS) for diabetes?

A
  • from differentiated beta cells in vitro, and introduce through hepatic portal vein to lodge into liver
  • iPS cell line can be a genetic match, alleviating need for immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the alternative therapies for Parkinson’s disease?

A

administration of L-DOPA and deep brain electrical stimulation may prove more effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the potential therapies using pluripotent stem cells (ES or iPS) for spinal repair?

A

demyelinating cells to treat spinal trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the potential therapies using pluripotent stem cells (ES or iPS) for vision (macular degeneration)?

A
  • clinical trials involved goal of demonstrating safety
  • immunoprivileged nature of eye avoids issues of tolerance to foreign antigens
  • low doses possible due to local focus of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

post-mitotic tissue

A
  • muscle and neuronal
  • nondividing cells and contain few or NO stem cells
  • skeletal muscel contains satellite cells critical for regeneration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

expanding tissue

A
  • liver, kidney, thyroid
  • undergo an expansion only during juvenile growth and possess some stem cells that can generate new cells to repopulate tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

renewal cells

A
  • epitheial lining of intestine, stomach, epidermis of skin, testes, and hematopoietic system
  • undergo continual replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mRNA gene expression increases indicate _____ for pathways involved in proliferation, migration, and receptor signaling

A

upregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

_____ stem cells are therapeutically robust, and represent major forms of treatment

A

resident (multipotent) stem cells

17
Q

use of _____ and _____ stem cells represents important research tools

A

ES and iPS (pluripotent) stem cells

18
Q

what is the major value of human pluripotent stem cells (iPS)?

A

to study human embryonic development and assess drug screening without needing embryos

19
Q

what is a challenge of the potential therapies using pluripotent stem cells (ES or iPS) for Parkinson’s disease?

A

challenge is the neurons be replaced in proper context positions in tissue with proper connectivity

20
Q

what are the safety concerns for the potential therapies using pluripotent stem cells (ES or iPS) for Parkinson’s disease?

A

persistence of a few pluripotent cells in graft that may form teratomas